Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for portosinusoidal vascular disease has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for portosinusoidal vascular disease.
31 publications have been identified in PubMed for portosinusoidal vascular disease. Research spans Case Report / Case Series (32%), Review / Meta-Analysis (23%), and Basic Science / Preclinical (23%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 10 | 32% |
Data assembled from 3 of 12 sources · Last updated Nov 4, 2026, 2:12 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Research summaries
7 |
23% |
Laboratory research | 7 | 23% |
Disease patterns and progression | 3 | 10% |
Testing and diagnosis research | 2 | 6% |
Clinical study results | 2 | 6% |
Wang X (2026). [PMID: 42023120](https://pubmed.ncbi.nlm.nih.gov/42023120/). *Front Med (Lausanne)*. [Case Report / Case Series]
Unknown (2026). [PMID: 41224629](https://pubmed.ncbi.nlm.nih.gov/41224629/). *Journal of hepatology*. [Review / Meta-Analysis]
Zhang H (2026). [PMID: 41966479](https://pubmed.ncbi.nlm.nih.gov/41966479/). *Clin Res Hepatol Gastroenterol*. [Case Report / Case Series]
Corvilain E (2026). [PMID: 41762359](https://pubmed.ncbi.nlm.nih.gov/41762359/). *Journal of clinical immunology*. [Basic Science / Preclinical]
Gopalakrishna H (2026). [PMID: 41410017](https://pubmed.ncbi.nlm.nih.gov/41410017/). *Clinical and translational gastroenterology*. [Epidemiology / Natural History]
Khandakar B (2026). [PMID: 41297617](https://pubmed.ncbi.nlm.nih.gov/41297617/). *Human pathology*. [Case Report / Case Series]
Zhao R (2026). [PMID: 41797760](https://pubmed.ncbi.nlm.nih.gov/41797760/). *Frontiers in medicine*. [Case Report / Case Series]
Loon E (2025). [PMID: 40246668](https://pubmed.ncbi.nlm.nih.gov/40246668/). *Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society*. [Case Report / Case Series]
He Y (2025). [PMID: 41089713](https://pubmed.ncbi.nlm.nih.gov/41089713/). *Journal of clinical and translational hepatology*. [Clinical Trial Publication]
Pestana I (2025). [PMID: 39906509](https://pubmed.ncbi.nlm.nih.gov/39906509/). *GE Portuguese journal of gastroenterology*. [Case Report / Case Series]
AI-curated news mentioning portosinusoidal vascular disease
Updated Oct 16, 2026
A recent study identifies higher serum sCD14 as an independent biomarker for the risk of porto-sinusoidal vascular disease in patients with common variable immunodeficiency (CVID). This discovery could enhance risk stratification and management strategies for affected individuals.
A recent publication discusses the management of subclavian and axillary artery aneurysms in patients with connective tissue disease, highlighting the lack of dedicated guidelines for this rare vascular condition. The study emphasizes the therapeutic uncertainties faced by clinicians in treating these aneurysms.
A recent study highlights two cases of TAFRO syndrome misdiagnosed as liver disease due to porto-sinusoidal vascular disease. This research underscores the importance of accurate diagnosis in rare diseases.